QWM
UTHR icon

Quaker Wealth Management’s United Therapeutics UTHR Stock Holding History

Quaker Wealth Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.79K Hold
7
– – ﹤0.01% 369
2026
Q1 		$4.15K Hold
7
– – ﹤0.01% 353
2025
Q4 		$3.41K Hold
7
– – ﹤0.01% 388
2025
Q3 		$2.94K Sell
7
-1
-13% -$336 ﹤0.01% 360
2025
Q2 		$2.3K Buy
+8
New +$2.39K ﹤0.01% 388

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Quaker Wealth Management's UTHR Position: Q2 2026 in Review

Quaker Wealth Management held its United Therapeutics (UTHR) position steady in Q2 2026 at 7 shares worth $3.79K. The position accounts for ﹤0.01% of the portfolio, ranked #369.

Quaker Wealth Management first reported a position in UTHR in Q2 2025 and has held it in 5 quarters since. The position peaked at $4.15K in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Quaker Wealth Management held 7 shares of United Therapeutics worth $3.79K as of Q2 2026.
  • Quaker Wealth Management left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up ﹤0.01% of Quaker Wealth Management's portfolio in Q2 2026, its #369 holding.
  • Quaker Wealth Management first reported a position in United Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Quaker Wealth Management's United Therapeutics position peaked at $4.15K in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Quaker Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.